Peer Exchange

Overview of Cardiovascular Risks

Prevalence of CVD Associated With Hypercholesterolemia

Atopic Dermatitis: Age of Onset and Prevalence

Impact of Atopic Dermatitis: Pediatrics Versus Adults

Presentation and Severity of Atopic Dermatitis

Seeking Care for Atopic Dermatitis

Nonpharmacological Approach to Managing Atopic Dermatitis

Pediatric AD: State-of-the-Art Treatment

Pathogenesis of Inflammatory Bowel Disease

Identifying Progressive, Relapsing IBD

Inflammatory Bowel Disease Risk Stratification

IBD Prognostication and Management

Diagnosing Inflammatory Bowel Disease

Goals of Therapy for Inflammatory Bowel Disease

T2T Approach for Inflammatory Bowel Disease

Treating a Low-Risk Inflammatory Bowel Disease

Treating Moderate/High-Risk IBD

Surgery for an Inflammatory Bowel Disease

Challenges in Treating Schizophrenia

Counseling Patients With Schizophrenia on Relapse

Schizophrenia Relapses and Patient Well-Being

Treatment Nonadherence and Schizophrenia Relapses

Socioeconomic Burden of Treatment Adherence in Schizophrenia

Psychosocial Interventions for Schizophrenia

Challenges With Oral Antipsychotics for Schizophrenia

Long-Acting Injectable Antipsychotics for Schizophrenia

Barriers to Prescribing LAIs for Schizophrenia

Misperceptions and Underutilization of LAIs for Schizophrenia

NCBH Guidelines and LAI Therapy for Schizophrenia

Advantages of LAI Antipsychotics for Schizophrenia

Dosing LAI Antipsychotics for Schizophrenia

Early Initiation of LAI Therapy for Schizophrenia

Current LAI Options for Schizophrenia

Second-Generation LAIs for Schizophrenia

LAI Treatment Selection and Patient Factors

Patient-Physician Collaboration and Schizophrenia Outcomes

Clinical Subtypes of ADHD

Factors That Predispose for ADHD

ADHD: Patient QOL and Misconceptions

What Prompts Patients to Seek an Evaluation for ADHD

Accurately Diagnosing ADHD

Challenges With Diagnosing ADHD

Non-Pharmacological Strategies for ADHD

Non-Stimulant Therapy for ADHD

Short- and Intermediate-Acting Stimulants for ADHD

Long-Acting Stimulants for ADHD

Prodrug Therapy for ADHD

Treatments for ADHD: Efficacy and Safety Data

Substance Abuse and ADHD

Adult ADHD Treatment Recommendations

Switching Medication for ADHD

Multimodal Treatment of ADHD

Novel Nonstimulant Therapy for ADHD

Exciting Therapies Under Investigation for ADHD

Treating ADHD: Current Unmet Needs

Managing ADHD During COVID-19

Pathological Differences Between Allergic Asthma and Nonallergic Asthma

Prevalence and Burden of Allergic Asthma

Treating Allergic Asthma During the Emergence of COVID-19

Role of Biomarkers in Allergic Asthma

Effect of Eosinophils on Treatment of Allergic Asthma

Response Biomarkers to Determine Efficiency in Treating Asthma

Novel Biomarkers for Biologic Targeted Mechanisms

Omalizumab in the Treatment of Allergic Asthma

IL-5 Inhibitors for the Treatment of Allergic Asthma

Dupilumab for Moderate to Severe Asthma

Personal Experience With Biologics When Treating Allergic Asthma

Role of Biologic Therapies in Improving Pulmonary Function

Safety Concerns With Biologics During the COVID-19 Pandemic

Final Thoughts on Allergic Asthma